Use of sibutramine analogues to prevent the development of diabetes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 16, 2001
Grant Date -
N/A
app pub date -
Mar 17, 1999
filing date -
Sep 21, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R.sub.1 and R.sub.2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for reducing Insulin resistance in humans in whom Impaired Glucose Tolerance and Non-Insulin Dependent Diabetes Mellitus have not presented.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully